- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| GNI GROUP Aktie jetzt für 0€ handeln | |||||
| 18.08. | A ¥6.6bn Reversal, Not Sales Growth, Pushed GNI Group Into the Black | - | Tokyo Brief | ||
| 02.07. | GNI Group Ltd.: GNI Group Completes Acquisition of AYUMI Pharmaceutical | 196 | GlobeNewswire (Europe) | TOKYO, July 01, 2026 (GLOBE NEWSWIRE) -- GNI Group Ltd. (TSE: 2160, "GNI Group" or the "Company") today announced that it has completed the acquisition of all shares of Ayumi Pharmaceutical Holdings... ► Artikel lesen | |
| 08.06. | GNI Group To Acquire Ayumi Pharmaceutical Holdings From Blackstone For About ¥44.8 Billion | 3 | pulse2.com | ||
| 08.06. | GNI Group to acquire Ayumi Pharmaceutical for ¥44.8 billion | 1 | Investing.com | ||
| 08.06. | GNI Group Ltd.: GNI Group to Acquire Ayumi Pharmaceutical Holdings, Expanding Its Position as a Global Biopharmaceutical Company | 296 | GlobeNewswire (Europe) | TOKYO, June 07, 2026 (GLOBE NEWSWIRE) -- GNI Group Co., Ltd. (TSE: 2160) today announced that it has entered into an agreement to acquire 100% of the shares of Ayumi Pharmaceutical Holdings Co., Ltd.... ► Artikel lesen |
5 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| DIGICANN VENTURES | 0,004 | -11,11 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| SINOPHARM | 1,708 | 0,00 % | Harbour BioMed and Sinopharm Enter Strategic Collaboration to Establish Innovation R&D Consortium | CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 27, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed... ► Artikel lesen | |
| CSPC PHARMA | 0,974 | +1,12 % | CSPC PHARMA Two Injection Products Approved for Clinical Trials in China | ||
| ORAMED PHARMACEUTICALS | 3,985 | 0,00 % | Oramed Pharmaceuticals Inc.: Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet | Significant Appreciation in Alpha Tau (NASDAQ: DRTS) Position (up ~$128 Million)
Scilex (NASDAQ: SCLX) Loan Substantially Repaid
Total Cash and Assets Build... ► Artikel lesen | |
| ADASTRA | 0,127 | -100,00 % | CSE Bulletin: Suspensions - Adastra Holdings Ltd., CAT Strategic Metals Corporation, Greenrise Global Brands Inc., StickIt Technologies Inc. | Le 12 mai/May 2026
Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101... ► Artikel lesen | |
| CATALYST PHARMACEUTICALS | 27,300 | +2,63 % | Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals | The Italian pharma company grows its presence in the U.S. market and strengthens its global leadership in Brain Health and Rare DiseasesCompletion of the transaction gives Angelini Pharma ownership... ► Artikel lesen | |
| METRIOPHARM | - | - | Press Release: MetrioPharm AG: Prof. Dr. med. Jürgen Braun Appointed as New Member of the Scientific Advisory Board | Press Release: MetrioPharm AG: Prof. Dr. med. Jürgen Braun Appointed as New Member of the Scientific Advisory Board
-- Prof. Dr. med. Jürgen Braun joins the Scientific Advisory Board of
MetrioPharm... ► Artikel lesen | |
| MOLECULE HOLDINGS | 0,001 | 0,00 % | Molecule Holdings Inc: Molecule receives partial revocation order of FFCTO | ||
| TETRA BIO-PHARMA | - | - | Why GrowPros Solutions Builds the Best Performing Under Canopy Lights in the Industry | ||
| NUMINUS WELLNESS | 0,027 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.04.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 23.04.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.04.2026ISIN NameAU000000BMG3 BMG... ► Artikel lesen | |
| BAYER | 48,170 | -1,09 % | Nicht nur Bayer verdient am Weltmarkt mit, ohne überall selbst präsent zu sein: Ein australischer Psychedelika-Anbieter setzt auf dasselbe Grundprinzip | ||
| MERCK KGAA | 131,45 | -0,15 % | BARCLAYS stuft MERCK KGAA auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Merck KGaA von 140 auf 150 Euro angehoben, aber die Einstufung auf "Equal Weight" belassen. Analyst James Gordon... ► Artikel lesen | |
| YARROW BIOSCIENCE | 27,010 | 0,00 % | Yarrow Bioscience prices $150M public offering of common stock at $26 per share | ||
| BIODEXA PHARMACEUTICALS | 1,295 | -0,38 % | Biodexa Pharmaceuticals PLC: Interim results for the six months ended June 30, 2026 | September 11, 2026 Biodexa Pharmaceuticals PLC("Biodexa" or the "Company") Interim results for the six months ended June 30, 2026 Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical-stage biopharmaceutical... ► Artikel lesen | |
| NOVO NORDISK | 37,045 | -0,15 % | Novo Nordisk machte GLP-1 zum Milliardenmarkt, CAR-T die Krebsmedizin - welche Biotech-Plattform kommt als Nächstes? |
Das Unternehmen GNI GROUP LTD kann der Branche Pharma zugeordnet werden. Der aktuelle Kurs liegt bei 15,800 Euro und damit -1,25 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GNI GROUP LTD finden Sie auf Wallstreet Online.